Efficient Hit-to-Lead Finding Capabilities for Potent and Selective Biological Outcomes
- Version:
- 21301
- Year:
- 2022
Overview: Key Tools for Designing Successful Fully Tailored Screening
Identifying biologically and pharmacologically active compound series with desired potency, selectivity, and ADME-toxicology properties in early phases of drug discovery requires team expertise across multiple disciplines, including chemistry, high-throughput screening (HTS), ADME, safety pharmacology, toxicology, bioinformatics, automation and translational biology.